{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T21:45:16Z","timestamp":1786571116754,"version":"build-2736575974"},"reference-count":48,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,8,10]],"date-time":"2021-08-10T00:00:00Z","timestamp":1628553600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:p>Critical limb ischemia (CLI) is the most advanced clinical stage of peripheral vascular disease with high mobility and mortality. CLI patients suffer from lower extremity rest pain, ulceration, and gangrene caused by insufficient blood and oxygen supply. Seeking for effective biomarkers and therapeutic targets is of great significance for improving the life quality of CLI patients. The circadian clock has been reported to be involved in the progression of kinds of cardiovascular diseases. Whether and how circadian genes play a role in CLI remains unknown. In this study, by collecting femoral artery and muscle specimens of CLI patients who underwent amputation, we confirmed that the circadian gene Bmal1 is downregulated in the CLI femoral artery and ischemic distal lower limb muscle. Furthermore, we verified that Bmal1 affects CLI by regulating lipid metabolism, inflammation, and angiogenesis. A hindlimb ischemia model performed in wild-type and Bmal1<jats:sup>\u2212\/\u2212<\/jats:sup> mice confirmed that Bmal1 disruption would lead to impaired angiogenesis. <jats:italic>In vitro<\/jats:italic> experiments indicated that the decreased expression of Bmal1 would increase ox-LDL uptake and impair endothelial cell functions, including proliferation, migration, and tube formation. As for mechanisms, Bmal1 represses inflammation by inhibiting lipid uptake and by activating IL-10 transcription and promotes angiogenesis by transcriptionally regulating VEGF expression. In conclusion, we provide evidence that the circadian gene Bmal1 plays an important role in CLI by inhibiting inflammation and promoting angiogenesis. Thus, Bmal1 may be an effective biomarker and a potential therapeutic target in CLI.<\/jats:p>","DOI":"10.3389\/fcvm.2021.712903","type":"journal-article","created":{"date-parts":[[2021,8,10]],"date-time":"2021-08-10T16:30:19Z","timestamp":1628613019000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":30,"title":["Bmal1 Downregulation Worsens Critical Limb Ischemia by Promoting Inflammation and Impairing Angiogenesis"],"prefix":"10.3389","volume":"8","author":[{"given":"Lirong","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yutong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianyun","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ye","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaolang","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daqiao","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junhao","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changpo","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,8,10]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1007\/s11739-011-0683-7","article-title":"Critical limb ischemia","volume":"6","author":"Gresele","year":"2011","journal-title":"Intern Emerg Med."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.3892\/etm.2019.7726","article-title":"Protective effect of rivaroxaban on arteriosclerosis obliterans in rats through modulation of the toll-like receptor 4\/NF-\u03baB signaling pathway","volume":"18","author":"Lou","year":"2019","journal-title":"Exp Ther Med."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1001\/jamasurg.2016.2018","article-title":"The current state of critical limb ischemia: a systematic review","volume":"151","author":"Farber","year":"2016","journal-title":"JAMA Surg."},{"key":"B4","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1177\/1358863X19843180","article-title":"Toll-like receptors 2 and 6 mediate apoptosis and inflammation in ischemic skeletal myotubes","volume":"4","author":"Patel","year":"2019","journal-title":"Vasc Med."},{"key":"B5","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.jvs.2013.06.054","article-title":"Potential role of erythropoietin receptors and ligands in attenuating apoptosis and inflammation in critical limb ischemia","volume":"60","author":"Joshi","year":"2014","journal-title":"J Vasc Surg."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1536\/ihj.17-592","article-title":"Outcomes in patients with critical limb ischemia due to arteriosclerosis obliterans who did not undergo arterial reconstruction","volume":"59","author":"Akagi","year":"2018","journal-title":"Int Heart J."},{"key":"B7","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1177\/1538574416628654","article-title":"Dyslipidemia part 1\u2014review of lipid metabolism and vascular cell physiology","volume":"2","author":"Helkin","year":"2016","journal-title":"Vasc Endovasc Surg."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2013\/152786","article-title":"ALOX-1, OxLDL, and atherosclerosis","volume":"2013","author":"Pirillo","year":"2013","journal-title":"Mediat Inflamm."},{"key":"B9","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1161\/CIRCULATIONAHA.107.745174","article-title":"Impact of plasma oxidized low-density lipoprotein removal on atherosclerosis","volume":"118","author":"Ishigaki","year":"2008","journal-title":"Circulation."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.vph.2016.05.013","article-title":"Physiology and pathophysiology of oxLDL uptake by vascular wall cells in atherosclerosis","volume":"84","author":"Di Pietro","year":"2016","journal-title":"Vasc Pharmacol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1056\/NEJMra043430","article-title":"Inflammation, atherosclerosis, and coronary artery disease","volume":"352","author":"Hansson","year":"2005","journal-title":"N Engl J Med."},{"key":"B12","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1007\/BF03402102","article-title":"Interleukin-10 deficiency increases atherosclerosis, thrombosis, and low-density lipoproteins in apolipoprotein E knockout mice","volume":"9","author":"Caligiuri","year":"2003","journal-title":"Mol Med."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1161\/01.RES.0000018941.10726.FA","article-title":"Overexpression of interleukin-10 by activated T lymphocytes inhibits atherosclerosis in LDL receptor\u2013deficient mice by altering lymphocyte and macrophage phenotypes","volume":"90","author":"Pinderski","year":"2002","journal-title":"Circ Res."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1172\/JCI18607","article-title":"Disruption of TGF-\u03b2 signaling in T cells accelerates atherosclerosis","volume":"112","author":"Robertson","year":"2003","journal-title":"J Clin Invest."},{"key":"B15","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1124\/pr.56.4.3","article-title":"Vascular endothelial growth factor and angiogenesis","volume":"56","author":"Hoeben","year":"2004","journal-title":"Pharmacol Rev."},{"key":"B16","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1161\/hy1201.097200","article-title":"Hypoxia-inducible factor-1alpha\/vascular endothelial growth factor pathway for adventitial vasa vasorum formation in hypertensive rat aorta","volume":"39","author":"Kuwahara","year":"2002","journal-title":"Hypertension."},{"key":"B17","doi-asserted-by":"publisher","first-page":"65","DOI":"10.3389\/fcvm.2017.00065","article-title":"Angiogenesis, cancer, and vascular aging","volume":"4","author":"Moriya","year":"2017","journal-title":"Front Cardiovasc Med."},{"key":"B18","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/j.tem.2016.03.015","article-title":"Circadian metabolism: from mechanisms to metabolomics and medicine","volume":"27","author":"Brown","year":"2016","journal-title":"Trends Endocrin Met."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1126\/science.1108750","article-title":"Obesity and metabolic syndrome in circadian clock mutant mice","volume":"308","author":"Turek","year":"2005","journal-title":"Science."},{"key":"B20","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.yjmcc.2017.01.008","article-title":"Disrupting the key circadian regulator CLOCK leads to age-dependent cardiovascular disease","volume":"105","author":"Alibhai","year":"2017","journal-title":"J Mol Cell Cardiol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"H475","DOI":"10.1152\/ajpheart.00238.2012","article-title":"Development of dilated cardiomyopathy in Bmal1-deficient mice","volume":"303","author":"Lefta","year":"2012","journal-title":"Heart Circ Physiol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"13011","DOI":"10.1038\/ncomms13011","article-title":"Global and hepatocyte-specific ablation of Bmal1 induces hyperlipidaemia and enhances atherosclerosis","volume":"7","author":"Pan","year":"2016","journal-title":"Nat Commun."},{"key":"B23","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.atherosclerosis.2007.12.059","article-title":"The relation of exposure to shift work with atherosclerosis and myocardial infarction in a general population","volume":"201","author":"Haupt","year":"2008","journal-title":"Atherosclerosis."},{"key":"B24","doi-asserted-by":"publisher","first-page":"R432","DOI":"10.1016\/j.cub.2016.04.011","article-title":"The circadian clock and human health","volume":"26","author":"Roenneberg","year":"2016","journal-title":"Curr Biol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1191\/135886399670596924","article-title":"Circadian variation and triggering of cardiovascular events","volume":"4","author":"Willich","year":"1999","journal-title":"Vasc Med."},{"key":"B26","doi-asserted-by":"publisher","first-page":"857","DOI":"10.5603\/CJ.a2019.0021","article-title":"Tachycardia: the hidden cardiovascular risk factor in uncomplicated arterial hypertension","volume":"27","author":"Cierpka-Kmiec","year":"2020","journal-title":"Cardiol J."},{"key":"B27","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/S0049-3848(98)00127-3","article-title":"Circadian variation in the onset of acute critical limb ischemia","volume":"92","author":"Manfredini","year":"1998","journal-title":"Thromb Res."},{"key":"B28","doi-asserted-by":"publisher","first-page":"1758","DOI":"10.1161\/CIRCULATIONAHA.113.002885","article-title":"Impaired cholesterol metabolism and enhanced atherosclerosis in clock mutant mice","volume":"128","author":"Pan","year":"2013","journal-title":"Circulation."},{"key":"B29","doi-asserted-by":"publisher","first-page":"e15","DOI":"10.1161\/CIRCRESAHA.119.315502","article-title":"BMAL1-downregulation aggravates porphyromonas gingivalis-induced atherosclerosis by encouraging oxidative stress","volume":"126","author":"Xie","year":"2020","journal-title":"Circ Res"},{"key":"B30","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1096\/fj.201601030R","article-title":"Myeloid Bmal1 deletion increases monocyte recruitment and worsens atherosclerosis","volume":"31","author":"Huo","year":"2017","journal-title":"FASEB J."},{"key":"B31","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1038\/nature10146","article-title":"Progress and challenges in translating the biology of atherosclerosis","volume":"473","author":"Libby","year":"2011","journal-title":"Nature."},{"key":"B32","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/j.intimp.2015.07.001","article-title":"Overexpression of CRY1 protects against the development of atherosclerosis via the TLR\/NF-\u03baB pathway","volume":"28","author":"Yang","year":"2015","journal-title":"Int Immunopharmacol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1016\/j.bbrc.2015.03.070","article-title":"Suppression of atherosclerosis by synthetic REV-ERB agonist","volume":"460","author":"Sitaula","year":"2015","journal-title":"Biochem Bioph Res Commun."},{"key":"B34","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.cmet.2013.12.016","article-title":"Circadian clocks and feeding time regulate the oscillations and levels of hepatic triglycerides","volume":"19","author":"Adamovich","year":"2014","journal-title":"Cell Metab"},{"key":"B35","doi-asserted-by":"publisher","first-page":"1800","DOI":"10.1194\/jlr.M900085-JLR200","article-title":"Clock is important for food and circadian regulation of macronutrient absorption in mice","volume":"50","author":"Pan","year":"2009","journal-title":"J Lipid Res."},{"key":"B36","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1038\/nature11030","article-title":"Regulation of circadian behaviour and metabolism by synthetic REV-ERB agonists","volume":"485","author":"Solt","year":"2012","journal-title":"Nature."},{"key":"B37","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1191\/1358863x03vm466oa","article-title":"High circulating levels of cytokines (IL-6 and TNFa), adhesion molecules (VCAM-1 and ICAM-1) and selectins in patients with peripheral arterial disease at rest and after a treadmill test","volume":"8","author":"Signorelli","year":"2003","journal-title":"Vasc Med."},{"key":"B38","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1126\/science.1240636","article-title":"Circadian gene Bmal1 regulates diurnal oscillations of Ly6C(hi) inflammatory monocytes","volume":"341","author":"Nguyen","year":"2013","journal-title":"Science."},{"key":"B39","doi-asserted-by":"publisher","first-page":"407","DOI":"10.4049\/jimmunol.1301982","article-title":"A circadian clock gene, Rev-erbalpha, modulates the inflammatory function of macrophages through the negative regulation of Ccl2 expression","volume":"192","author":"Sato","year":"2014","journal-title":"J Immunol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/s10456-019-09689-7","article-title":"Role of melatonin in controlling angiogenesis under physiological and pathological conditions","volume":"23","author":"Qiang","year":"2020","journal-title":"Angiogenesis."},{"key":"B41","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1038\/35025220","article-title":"Angiogenesis in cancer and other diseases","volume":"407","author":"Carmeliet","year":"2000","journal-title":"Nature."},{"key":"B42","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1097\/MOL.0000000000000339","article-title":"Plaque angiogenesis and its relation to inflammation and atherosclerotic plaque destabilization","volume":"27","author":"de Vries","year":"2016","journal-title":"Curr Opin Lipidol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1089\/hum.2006.17.683","article-title":"Treatment with intramuscular vascular endothelial growth factor gene compared with placebo for patients with diabetes mellitus and critical limb ischemia","volume":"17","author":"Kusumanto","year":"2006","journal-title":"Hum Gene Ther."},{"key":"B44","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.1016\/S0140-6736(11)60394-2","article-title":"Effect of fibroblast growth factor NV1FGF on amputation and death: a randomised placebo-controlled trial of gene therapy in critical limb ischaemia","volume":"377","author":"Belch","year":"2011","journal-title":"Lancet."},{"key":"B45","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1161\/CIRCULATIONAHA.107.727347","article-title":"Vascular medicine results of a double-blind, placebo-controlled study to assess the safety of intramuscular injection of hepatocyte growth factor plasmid to improve limb perfusion in patients with critical limb ischemia","volume":"9","author":"Powell","year":"2008","journal-title":"Circulation."},{"key":"B46","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1016\/j.jvs.2010.07.044","article-title":"Safety and efficacy of patient specific intramuscular injection of HGF plasmid gene therapy on limb perfusion and wound healing in patients with ischemic lower extremity ulceration: results of the HGF-0205 trial","volume":"52","author":"Powell","year":"2010","journal-title":"J Vasc Surg."},{"key":"B47","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1161\/CIRCULATIONAHA.110.009407","article-title":"Effect of hypoxia-inducible factor-1\u03b1 gene therapy on walking performance in patients with intermittent claudication","volume":"124","author":"Creager","year":"2011","journal-title":"Circulation."},{"key":"B48","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.vph.2012.02.002","article-title":"Hepatocyte growth factor stimulated angiogenesis without inflammation: differential actions between hepatocyte growth factor, vascular endothelial growth factor and basic fibroblast growth factor","volume":"57","author":"Kaga","year":"2012","journal-title":"Vasc Pharmacol."}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2021.712903\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,10]],"date-time":"2021-08-10T16:30:21Z","timestamp":1628613021000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2021.712903\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,10]]},"references-count":48,"alternative-id":["10.3389\/fcvm.2021.712903"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2021.712903","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,10]]},"article-number":"712903"}}